| Identification | Back Directory | [Name]
Rivabazumab | [CAS]
1627519-84-9 | [Synonyms]
Rivabazumab Research Grade Rivabazumab Research Grade Rivabazumab (DXX03402) |
| Hazard Information | Back Directory | [Uses]
Rivabazumab is a recombinant antibody against Pseudomonas aeruginosa pcrV[1]. | [References]
[1] Wenshe Ray LIU, et al. Protease switch for dual targets chimeric antigen receptor t cell therapy. WO2021087245. |
|
| Company Name: |
Biolab Reagents
|
| Tel: |
027-65279366 18108604356 |
| Website: |
www.biolabreagent.com/ |
| Company Name: |
Cell Sciences
|
| Tel: |
9785721070 |
| Website: |
www.cellsciences.com |
| Company Name: |
Biorbyt Ltd.
|
| Tel: |
+44 (0)1223 859 353 |
| Website: |
http://www.biorbyt.com |
|